Wednesday 8 September 2021 6:00pm to 7:45pm
About
Open to all scientists researching new therapeutics in Cambridge and the local area.
The purpose of the CamNTF is to promote interactions between scientists from academia & industry in order to improve opportunities for biotechnology research and development. Meeting attendance is free but all attendees must register in advance. The upcoming September event, our first after the summer break, will be hosted by AstraZeneca
Host: AstraZeneca
Date: Wednesday 8th September 2021
Location: This event will take place online. Please register on Eventbrite and joining details will be circulated prior to the event.
Register: https://camntfseptember2021meeting.eventbrite.co.uk
Programme
18:00 – Welcome: Dr Mark Fidock, Vice President, Diagnostic Development, Precision Medicine and Biosamples, R&D Oncology, AstraZeneca
18:05 – Dr Pedro Folegatti MD, Clinical Research Fellow at the Centre for Clinical Vaccinology and Tropical Medicine / The Jenner Institute, University of Oxford.
Talk title: ChAdOx1 vectored vaccines preceding SARS-CoV-2
18:30 – Dr Anetta Ptasinska, Biomarker Validation Scientist at the Institute of Cancer and Genomics, University of Birmingham
Talk title: Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations
18:55 – Dr Jiandong Huo, Post Doc, Division of Structural Biology, University of Oxford
Talk title: The deus ex machine of the nanobodies
19:10 – Post-talk speaker panel - Led by Dr Shethah Morgan, Senior Group Director, Clinical Development Immunology, R&D Biopharmaceuticals, AstraZeneca
19:40 – Meeting close
Register here: https://camntfseptember2021meeting.eventbrite.co.uk